Accurate diagnosis of AL amyloidosis is crucial and involves key tests like immunofixation electrophoresis and urine tests. Screening for organ damage is performed through renal function assessments and cardiac MRIs. Biopsies are essential for detecting amyloid. The Andromeda trial has introduced daratumumab as a leading treatment, aiming for complete hematologic remission. Autologous stem cell transplantation may be considered for responsive patients, with future therapies potentially enhancing survival rates.

AI has been used for both descriptions and subtitles, even though it has been checked, there may be errors.